login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
AGILE THERAPEUTICS INC (AGRX) Stock News
NASDAQ:AGRX -
US00847L3087
-
Common Stock
0.6022
USD
+0.06 (+10.11%)
Last: 3/25/2024, 8:08:50 PM
0.2408
USD
-0.36 (-60.01%)
After Hours:
3/25/2024, 8:08:50 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AGRX Latest News, Press Relases and Analysis
All
Press Releases
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
a year ago - By: InvestorPlace
AGRX Stock Earnings: Agile Therapeutics Reported Results for Q2 2024
a year ago - By: Halper Sadeh LLC
- Mentions:
ENV
SPR
UMBF
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENV, SPR, UMBF, AGRX on Behalf of Shareholders
a year ago - By: BusinessInsider
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024
a year ago - By: BusinessInsider
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023
a year ago - By: Benzinga
Agile Therapeutics: Q4 Earnings Insights
a year ago - By: Benzinga
Agile Therapeutics's Earnings: A Preview
a year ago - By: Halper Sadeh LLC
- Mentions:
INFN
SPR
GRDI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INFN, SPR, AGRX, GRDI on Behalf of Shareholders
a year ago - By: Halper Sadeh LLC
- Mentions:
ALIM
SHCR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SHCR, AGRX on Behalf of Shareholders
a year ago - By: Kahn Swick & Foti, LLC
AGILE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Agile Therapeutics, Inc. - AGRX
2 years ago - By: InvestorPlace
- Mentions:
DPRO
BZFD
Why Is Draganfly (DPRO) Stock Down 48% Today?
2 years ago - By: InvestorPlace
- Mentions:
BZFD
Why Is BuzzFeed (BZFD) Stock Up 101% Today?
a year ago - By: Halper Sadeh LLC
AGRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Agile Therapeutics, Inc. Is Fair to Shareholders
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
a year ago - By: InvestorPlace
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
2 years ago - By: InvestorPlace
- Mentions:
TDOC
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today?
a year ago - By: InvestorPlace
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Announces Delisting from Nasdaq
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Announces Delisting from Nasdaq
a year ago - By: Agile Therapeutics, Inc.
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
a year ago - By: Agile Therapeutics, Inc.
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
a year ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
2 years ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
2 years ago - By: Agile Therapeutics, Inc.
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
2 years ago - By: InvestorPlace
- Mentions:
DPRO
BZFD
Why Is Bel Fuse (BELFB) Stock Down 17% Today?
Please enable JavaScript to continue using this application.